High-field structural and functional MRI to investigate the substrates of fatigue in multiple sclerosis and to monitor the effect of tailored treatments.Pharmacological substudy.
Phase of Trial: Phase II
Latest Information Update: 10 Oct 2015
At a glance
- Drugs Amantadine (Primary) ; Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 25 Apr 2015 Results presented at the 67th Annual Meeting of the American Academy of Neurology.
- 21 Feb 2015 New trial record